CKDBio
CKDBio is a leading microbiome CDMO in Asia, offering end-to-end solutions from Cell Bank to DS and DP under pharmaceutical-grade GMP. With over 50 years of microbial fermentation expertise and specialized capabilities in strict anaerobes, we support preclinical to early clinical development with scalable GMP manufacturing. Our integrated anaerobic platform, validated QC methods, and global IND/clinical supply experience supporting programs including MFDS (Korea), FDA (USA), and TGA (Australia). CKD Bio promises client-centric approach that enables fast, reliable, and high-quality development of next-generation microbiome therapies.
